TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
47 hedge funds and large institutions have $14.1M invested in Titan Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
4
Closed
8
Calls
$1.11M
Puts
$6K
Net Calls
+$1.1M
Net Calls Change
+$45K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$620K |
| 2 |
Renaissance Technologies
New York
|
+$586K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$345K |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
+$315K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$260K |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$305K |
| 2 |
Millennium Management
New York
|
-$146K |
| 3 |
SIM
Spark Investment Management
New York
|
-$141K |
| 4 |
SG Americas Securities
New York
|
-$96K |
| 5 |
Walleye Trading
New York
|
-$89K |
